Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...

As of early 2024, Thermo Fisher carried roughly $36 billion in long- and short-term obligations. The PPD acquisition materially increased its leverage (2.6 debt/EBITDA for 2023) but we anticipate this ...

Thermo FisherScientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to ...

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations ...

Thermo Fisher Scientific Inc. ( NYSE:TMO) showcases robust revenue growth despite a challenging macroeconomic environment.

The Zacks Daily presents the best research output of our analyst team. Today's Daily features new research reports on 16 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Mutual Advisors LLC lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 10.9% in the 3rd quarter, according to its most recent Form 13F filing with the ...

The fetal abnormality test measures the most common chromosomal abnormalities, including Down syndrome, via a single-tube PCR process.